All News

FDA approves a new molecular entity, Kuvan, to treat phenylketonuria.

Pharmacists speak out about a behind-the-counter class of drugs, pharmacy coupons, and Mevacor going OTC.

Here are the winners of the Drug Topics' 150th Anniversary history contest

In a speech to its employees, Wal-Mart CEO signals the company's intention to get into the pharmacy benefit management business

The Centers for Medicare & Medicaid Services is seeking comment on the draft of its 2009 call letter for prescription drug plans.

New York governor proposes bulk prescription drug purchasing and a discount Rx Card in a new budget proposal.

First generic alendronate sodium tablets approved

Injectable colchicine is removed from the market by FDA

CVS Samaritan Van program celebrates 30 years of helping motorists

VTE under treated according to ENDORSE

Groups call for moratorium on Bisphenol A in baby bottles, food, beverage containers

PhRMA applauds resolution creating National Drug Prevention and Education Week

Drug distributors save healthcare system nearly $34 billion a year

Washington authorities sentence two individuals who helped a pharmacy defraud Medicaid

Aetna insists the average colonoscopy patient does not need the presence of an anesthesiologist to administer propofol.

FDA issues public health advisory on varenicline

Mometasone powder approved for younger children

FDA recalls several SynchroMed EL Implantable Infusion Pump models

NCPA applauds White House's creation of task force to end teenage prescription drug abuse

AAHomecare: President's proposed budget would weaken seniors' access to DME

GSK offering free OTC smoking cessation products to help consumers stop smoking

Many physicians reported in a survey that a Medicare decision on erythropoiesis stimulating agents has hurt their patients.

An online Drug Topics poll finds that community pharmacists think there's still room for them to get into specialty pharmacy.

Study finds widespread vitamin and mineral use among cancer survivors

FDA approves revised labeling for Thrombin-JMI.

NACDS launches advertising campaign touting pharmacy.

The National Council for Prescription Drug Programs urges physicians to get going on ordering tamper-resistant Rx pads.

FDA approves zotarolimus drug-eluting stent